Safety and immunogenicity of the therapeutic vaccine TG1050 in chronic hepatitis B patients: a phase 1b placebo-controlled trial

F Zoulim, C Fournier, F Habersetzer… - Human Vaccines & …, 2020 - Taylor & Francis
Treatment of chronic hepatitis B (CHB) typically requires life-long administration of drugs.
Cohort and pre-clinical studies have established the link between a functional T-cell …

T cell receptor profiling in type 1 diabetes

LM Jacobsen, A Posgai, HR Seay, MJ Haller… - Current diabetes …, 2017 - Springer
Abstract Purpose of Review The genetic susceptibility and dominant protection for type 1
diabetes (T1D) associated with human leukocyte antigen (HLA) haplotypes, along with …

The mutation-associated neoantigen functional expansion of specific T cells (MANAFEST) assay: a sensitive platform for monitoring antitumor immunity

L Danilova, V Anagnostou, JX Caushi… - Cancer immunology …, 2018 - AACR
Mutation-associated neoantigens (MANA) are a target of antitumor T-cell immunity.
Sensitive, simple, and standardized assays are needed to assess the repertoire of functional …

Age-related distribution and dynamics of T-cells in blood and lymphoid tissues of goats

M Baliu-Piqué, H Kurniawan, L Ravesloot… - Developmental & …, 2019 - Elsevier
Neonatal mammals have increased disease susceptibility and sub-optimal vaccine
responses. This raises problems in both humans and farm animals. The high prevalence of …

DNA vaccination by electroporation amplifies broadly cross-restricted public TCR clonotypes shared with HIV controllers

M Mukhopadhyay, M Galperin… - The Journal of …, 2017 - journals.aai.org
Rare patients who spontaneously control HIV replication provide a useful model to inform
HIV vaccine development. HIV controllers develop particularly efficient antiviral CD4+ T cell …

Transient IL-10 receptor blockade can enhance CD8+ T cell responses to a simian adenovirus-vectored HIV-1 conserved region immunogen

G Clutton, A Bridgeman… - Human vaccines & …, 2015 - Taylor & Francis
Viral vector vaccines designed to elicit CD8+ T cells in non-human primates exert potent
control of immunodeficiency virus infections; however, similar approaches have been …

Vaccine targeting of subdominant CD8+ T cell epitopes increases the breadth of the T cell response upon viral challenge, but may impair immediate virus control

MA Steffensen, LH Pedersen, ML Jahn… - The Journal of …, 2016 - journals.aai.org
As a result of the difficulties in making efficient vaccines against genetically unstable viruses
such as HIV, it has been suggested that future vaccines should preferentially target …